Skip links

Mastering Data for Optimal AI Performance: Strategies and Techniques

Jump To Section

Current economic conditions consisting of a labor shortage and high inflation which is accelerating costs are requiring that companies focus on productivity and automation. In 2021 overall investment grew 7.4% and for technology this rate was 14%.

Current economic conditions consisting of a labor shortage and high inflation, which is accelerating costs, require that companies focus on productivity and automation when investing in digital business. In 2021, overall investment grew 7.4%, and for technology, this rate was 14%. In 2022, it will increase anywhere from 7.7% to 10.3%, and the majority of these investments will be in CPG/retail, manufacturing (supply chain is a key area of focus), and the services industry. These investments are geared towards increasing productivity and improving the bottom line.

Digital Business investments

Examples of investments to improve productivity include Chipotle’s focus on automating repetitive tasks and Walmart’s emphasis on warehouse automation. In the automotive industry a key focus is on leveraging vehicle data that can be monetized to generate new value creation beyond vehicle manufacturing. Recently financial and professional service companies experienced a rise in productivity by creating a flexible working environment through remote work options. According to the Labor Department this has led to at least a one percent improvement in productivity.

Fostering Growth and Agility Through Digital Investments

What investments should companies make that drives sustainable growth and organizational agility to create value? The answer is digital business. Achieving digital maturity is also about simplification and automation to create an agile engineering culture enabling speed and scale. As companies ramp up their investments it is imperative that they focus on quickly delivering value and outcomes.

Investing in this approach enables flexible work environment leveraging global resources, gig workers, leading to simplification and automation. Most important among these is the ability to simplify any business function to create effective end-to-end workflows for collaboration. Data is brought together from various sources, is analyzed with an agile approach to create a single source of truth (SSOT). This can be applied to any business function leading to better decision making and transparency. In addition, applying appropriate algorithms like AI/ML to the SSOT will produce more effective predictive tools and facilitate innovation with speed in a cost-effective way. Digital business on its own will create unlimited opportunities and business models for growth with speed.

An MIT Technology Review article, The coming productivity boom, cited three reasons why productivity gains are expected to be bigger and faster than in the past. AI/ML, lower data storage costs, more powerful computing power, and cloud computing are driving the expected jump in productivity. Technology alone can’t achieve this; it must be done by creating a culture that fosters end-to-end collaboration between the business and technology. This is the pathway to enable growth through a SSOT and simplification to bring about a higher level of productivity and outcomes.

Final Thoughts

Digital business is the solution to achieve effective business outcomes with speed without disrupting the current business. This is accomplished by taking an incremental approach based on priority areas to deliver outcomes on key objectives. Bringing business and technology together to collaborate creates an end-to-end perspective that brings speed leading to new and innovative solutions. That translates to higher productivity levels and value creation in the coming years.

Picture of Raj Vattikuti

Raj Vattikuti

Raj Vattikuti is an American-Indian entrepreneur, business executive and philanthropist. He is the Founder and Chairman of Altimetrik Corp. He is also the founder of Vattikuti Foundation. through which he is involved in many charitable causes.

Latest Reads


Suggested Reading

Ready to Unlock Your Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes